Quanta in the News.

26 October 2015.  Seroba’s investee company, Quanta Fluid Solutions, has this week announced it has successfully treated the first patients with its portable, cartridge-based haemodialysis system.  The company has also featured on the BBC News in the UK.

The treatments were part of a pilot study designed to demonstrate safety, performance and usability of SC+ in a clinical setting with human dialysis patients.  The results showed that all
dialysis therapies were successfully and safely completed with no adverse events. Essential
performance criteria, including urea clearance and ultrafiltration rate, were assessed and
achieved their prescribed targets, clearly meeting the primary endpoints of the study.

Patients and clinicians were also asked to rate SC+ in terms of usability in comparison to
standard dialysis systems. Positive feedback was given on the simplicity and compact size of the machine, the unique cartridge concept and on the quietness of SC+ when running.

The first ten treatments were performed with six patients over a two-week period at
Nottingham University Hospitals NHS Trust in the United Kingdom. These treatments were
provided as in-centre, nurse-led haemodialysis therapy sessions at standard dialysate and
blood flow-rates.

Participants included male and female patients with chronic end stage renal disease, aged from 40 to 79 years-old and with weights ranging between 79.5kg and 154kg.  Since then, patients have continued to be treated at Nottingham, reaching over 40 successful treatments to date.

BBC News features Quanta.

Also in October 2015, the BBC news featured Quanta’s SC+ dialysis solution and spoke to some of the renal patients at Nottingham University Hospital NHS Trust in the UK.  You can view this BBC news feature here.

Guardian Newspaper features Quanta.

In February 2016, the Guardian newspaper ran a featured article on Quanta’s SC+ dialysis solution.  You can read that article here.

ENDS.

 

< back to home page